alvocidib   Click here for help

GtoPdb Ligand ID: 5680

Synonyms: flavopiridol | HL 275 | HMR 1275 | L 86-8275 | L 868275 | MDL-107826A | NSC-649890
PDB Ligand
Compound class: Synthetic organic
Comment: Alvocidib is a selective inhibitor of cyclin-dependent kinase (CDK) 2 and CDK4 [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 3
Rotatable bonds 2
Topological polar surface area 94.14
Molecular weight 401.1
XLogP 3.95
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES CN1CCC(C(C1)O)c1c(O)cc(c2c1oc(cc2=O)c1ccccc1Cl)O
Isomeric SMILES CN1CC[C@@H]([C@@H](C1)O)c1c(O)cc(c2c1oc(cc2=O)c1ccccc1Cl)O
InChI InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1
No information available.
Summary of Clinical Use Click here for help
Alvocidib has progressed to Phase 2 clinical evaluation for anti-cancer potential. Click here to link to's full list of alvocidib trials.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Alvocidib is a CDK kinase inhibitor [1,7] which causes cell-cycle arrest and subsequent apoptosis of cancer cells [2,4].